72
Participants
Start Date
March 31, 2011
Primary Completion Date
March 31, 2012
Study Completion Date
May 31, 2012
Piroxicam ( BAYl1902)
Single dose of 20 mg piroxicam (i.e., 1 piroxicam capsule + 3 placebo capsule)
Piroxicam ( BAYl1902)
Single dose of 40 mg piroxicam (i.e., 2 piroxicam capsules + 2 placebo capsule)
Placebo
Single dose of placebo (i.e., 4 placebo capsules)
Piroxicam ( BAYl1902)
Single dose of 80 mg piroxicam (i.e., 4 piroxicam capsules)
Berlin
Lead Sponsor
Bayer
INDUSTRY